|Nombre||Título||Paga||Ejecutado||Año de nacimiento|
|Mr. Carlos Gallardo Piqué||CEO & Chairman of the Board||50k||N/A||1972|
|Mr. Michael McClellan||Executive VP of Finance, CFO & Member of Management Board||N/A||N/A||1972|
|Mr. Eloi Crespo Cervera||Senior VP of Industrial Operations & Member of Management Board||N/A||N/A||N/A|
|Mr. Jordi Sabé Richer||Senior VP of Corporate Development & Member of Management Board||N/A||N/A||N/A|
|Mr. Esteve Conesa Panicot||Senior VP of Human Resources & Member of Management Board||N/A||N/A||N/A|
|Dr. Volker Koscielny||Chief Medical Officer & Member of Management Board||N/A||N/A||N/A|
|Mr. Pablo Alvarez||Member of Management Board, President of Almirall US & GM of Almirall US||N/A||N/A||N/A|
|Dr. Karl Ziegelbauer||Executive VP of R&D, CSO and Member of Management Board||N/A||N/A||N/A|
|Mr. Paolo Cionini||Chief Commercial Officer Europe & International and Member of Management Board||N/A||N/A||N/A|
|Ms. Isabel Gomes||General Counsel & Member of Management Board||N/A||N/A||N/A|
Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
El ISS Governance QualityScore de Almirall, S.A., a día 1 de diciembre de 2023, es 4. Las puntuaciones base son Auditoría: 4; Tablero: 4; Derechos de los accionistas: 3; Compensación: 6.